Artikel dengan mandat akses publik - a.mcguirePelajari lebih lanjut
Tidak tersedia di mana pun: 1
Price regulation and relative delays in generic drug adoption
J Costa-Font, A McGuire, N Varol
Journal of health economics 38, 1-9, 2014
Mandat: UK Economic and Social Research Council
Tersedia di suatu tempat: 35
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised …
International Carotid Stenting Study investigators
The Lancet 375 (9719), 985-997, 2010
Mandat: Swiss National Science Foundation
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK …
U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...
The lancet oncology 10 (4), 327-340, 2009
Mandat: US National Institutes of Health, Cancer Research UK
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
Mandat: Cancer Research UK, UK Medical Research Council, National Institute for …
Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial …
U Menon, A Ryan, J Kalsi, A Gentry-Maharaj, A Dawnay, M Habib, ...
Journal of Clinical Oncology 33 (18), 2062-2071, 2015
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial
R Manchanda, K Loggenberg, S Sanderson, M Burnell, J Wardle, ...
Journal of the National Cancer Institute 107 (1), dju379, 2015
Mandat: National Institute for Health Research, UK
Toward a consensus on the QALY
M Drummond, D Brixner, M Gold, P Kind, A McGuire, E Nord, ...
Value in Health 12, S31-S35, 2009
Mandat: US National Institutes of Health
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing
R Manchanda, R Legood, M Burnell, A McGuire, M Raikou, K Loggenberg, ...
Journal of the National Cancer Institute 107 (1), dju380, 2015
Mandat: National Institute for Health Research, UK
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a …
LH Bonati, J Gregson, J Dobson, DJH McCabe, PJ Nederkoorn, ...
The Lancet Neurology 17 (7), 587-596, 2018
Mandat: Swiss National Science Foundation, UK Medical Research Council, National …
Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study
U Menon, A Gentry-Maharaj, A Ryan, A Sharma, M Burnell, R Hallett, ...
Bmj 337, 2008
Mandat: US National Institutes of Health, Cancer Research UK
LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
M Anderson, E Pitchforth, M Asaria, C Brayne, B Casadei, A Charlesworth, ...
The Lancet 397 (10288), 1915-1978, 2021
Mandat: British Heart Foundation
Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists’ collaboration
D Calvet, JL Mas, A Algra, JP Becquemin, LH Bonati, J Dobson, ...
Stroke 45 (2), 527-532, 2014
Mandat: Swiss National Science Foundation, German Research Foundation, UK Medical …
Ovarian cancer symptoms, routes to diagnosis and survival–Population cohort study in the ‘no screen’arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
J Dilley, M Burnell, A Gentry-Maharaj, A Ryan, C Neophytou, ...
Gynecologic oncology 158 (2), 316-322, 2020
Mandat: Cancer Research UK, UK Medical Research Council, National Institute for …
The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks
M Bech, T Christiansen, K Dunham, J Lauridsen, CH Lyttkens, ...
Health economics 18 (10), 1114-1132, 2009
Mandat: Swiss National Science Foundation, US National Institutes of Health …
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
U Menon, AJ McGuire, M Raikou, A Ryan, SK Davies, M Burnell, ...
British journal of cancer 117 (5), 619-627, 2017
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, A Ryan, N Singh, R Manchanda, ...
The Lancet Oncology 24 (9), 1018-1028, 2023
Mandat: National Health and Medical Research Council, Australia, Cancer Research UK …
Hospital coordination and integration with social care in England: the effect on post-operative length of stay
JL Fernandez, A McGuire, M Raikou
Journal of health economics 61, 233, 2018
Mandat: National Institute for Health Research, UK
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, A Ryan, JK Kalsi, N Singh, ...
Health Technology Assessment (Winchester, England), 1, 2023
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
S Philpott, M Raikou, R Manchanda, M Lockley, N Singh, M Scott, ...
Journal of medical genetics 60 (5), 440-449, 2023
Mandat: National Institute for Health Research, UK, Target Ovarian Cancer, UK
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer